查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519356

2024-2032 年按給藥途徑、應用、最終用戶和地區分類的藥物傳輸市場報告

Pharmaceutical Drug Delivery Market Report by Route of Administration, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球藥品給藥市場規模達13,976億美元。對靶向高效藥物輸送系統的需求不斷成長、對促進藥物輸送創新的個人化醫療的日益關注以及奈米技術的眾多進步是推動藥物輸送市場佔有率的一些主要因素。

藥品給藥市場分析：

主要市場促進因素：慢性病的盛行率日益增加，增加了對標靶治療的需求，從而促進了市場的成長。此外，由於患者獨特的基因特徵需要量身定做的藥物管理方法，因此對個人化藥物的需求不斷成長，這也促進了市場的成長。

主要市場趨勢：奈米技術和生物材料的許多進步促進了精確的藥物傳遞機制，允許控制釋放和更好的生物利用度，對市場成長產生積極影響。此外，越來越多採用可滿足老年患者特定需求的使用者友善給藥系統也是推動市場成長的另一個重要趨勢。

地理格局：報告顯示，北美在全球市場中佔據最大的市場佔有率，因為該地區擁有健全的醫療基礎設施、強大的研發能力以及慢性病的高盛行率。

競爭格局：一些領先的藥物輸送市場公司包括艾伯維公司、安進公司、阿斯特捷利康公司、碧迪公司、禮來公司、葛蘭素史克公司、強生公司、默克公司、諾華公司、輝瑞公司。

挑戰與機會：全球藥物輸送市場的挑戰包括監管障礙、複雜的製造流程以及持續創新的需求。藥物傳輸市場近期的機會包括慢性病盛行率的增加、對標靶和受控藥物傳輸系統的需求不斷成長以及奈米技術和生物製劑的進步。

藥品給藥市場趨勢：

對標靶治療的需求不斷成長

對標靶治療的需求不斷成長是藥物傳輸市場的重要驅動力。傳統的全身給藥常常會導致脫靶效應和不良反應，這增加了對標靶治療和藥物傳遞的需求。此外，各種危及生命的感染（例如 COVID-19）的日益普及也促使製造商引入有效的藥物輸送設備和技術。預計這將在未來幾年對藥物輸送市場的成長做出重大貢獻。例如，2022年2月，Glenmark Pharmaceuticals Limited在印度推出了一種名為FabiSpray的一氧化氮鼻噴劑，用於治療病情進展風險較高的COVID-19成年患者。除此之外，Frontiers 2020年7月發表的文章提到，治療糖尿病需要根據藥物的性質開發合適的給藥系統和完善的治療策略。消息人士透露，藥物輸送裝置在糖尿病治療的各個方面都顯示出巨大的潛力。它們增強藥物的穩定性，克服生物障礙以提高生物利用度，並作為智慧自動化系統來模擬天然胰島素輸送，從而降低低血糖風險。

科技的快速進步

藥物傳輸設備和技術的持續技術進步使它們對患者更加友善、易於使用和準確，這進一步促進了全球藥物傳輸市場的成長。除此之外，各個主要市場參與者都在廣泛投資於先進藥物輸送設備的開發與創新。例如，2021 年 5 月，Phillips-Medisize 推出了 Aria 智慧自動注射器平台，該平台開啟了製藥業的創新、差異化和永續性。該設備採用先進技術，例如支援多種藥物配方和黏度的模組化藥物傳輸平台，並具有內建藍牙，可連接智慧型手機、平板電腦和行動應用程式。同樣，2021 年6 月，羅氏開發了一種帶有雷珠單抗(PDS)（一種藥物輸送植入物）的端口輸送系統，使患有濕性老年性黃斑部病變的患者無需進行頻繁的眼部注射。預計此類創新和技術進步將在未來幾年推動藥品輸送市場的收入。

慢性病盛行率增加

世界各地各種慢性疾病病例的不斷增加正在增加對藥物的需求。據世界衛生組織（WHO）稱，慢性病是全世界死亡的主要原因。 2019 年，光是缺血性心臟病就導致約 889 萬人死亡。根據國際癌症研究機構2020年公佈的資料，全球每5個人中就有1人在一生中患有癌症，每8名男性中就有1名、每11名女性中就有1名死亡。乳癌、大腸癌、肺癌、子宮頸癌和甲狀腺癌在女性中很常見。而肺癌和攝護腺癌在男性中最常見，佔所有男性癌症的近三分之一。此外，根據印度國家衛生研究院2022年發布的《慢性病盛行率和潛在決定因素》報告，印度約21%的老年人口患有至少一種慢性病。慢性疾病病例的不斷增加預計將提振藥物輸送市場的需求。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球藥品給藥市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依管理途徑

  • 口服給藥
    • 市場走向
    • 市場預測
  • 注射給藥
    • 市場走向
    • 市場預測
  • 局部給藥
    • 市場走向
    • 市場預測
  • 眼部藥物輸送
    • 市場走向
    • 市場預測
  • 肺部藥物輸送
    • 市場走向
    • 市場預測
  • 植入式藥物輸送
    • 市場走向
    • 市場預測
  • 經由黏膜給藥
    • 市場走向
    • 市場預測
  • 鼻腔給藥
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 傳染性疾病
    • 市場走向
    • 市場預測
  • 癌症
    • 市場走向
    • 市場預測
  • 心血管疾病
    • 市場走向
    • 市場預測
  • 糖尿病
    • 市場走向
    • 市場預測
  • 呼吸疾病
    • 市場走向
    • 市場預測
  • 中樞神經系統疾病
    • 市場走向
    • 市場預測
  • 自體免疫疾病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 家庭護理設置
    • 市場走向
    • 市場預測
  • 診斷中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Eli Lilly and Company
    • GSK plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
Product Code: SR112024A5796

The global pharmaceutical drug delivery market size reached US$ 1,397.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,157.1 Billion by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032. The rising demand for targeted and efficient drug delivery systems, increasing focus on personalized medicine fostering drug delivery innovations, and numerous advancements in nanotechnology are some of the major factors propelling the pharmaceutical drug delivery market share.

Pharmaceutical Drug Delivery Market Analysis:

Major Market Drivers: The increasing prevalence of chronic diseases is augmenting the demand for targeted therapies, which in turn is catalyzing the market growth. Furthermore, the rising need for personalized medication as unique genetic profiles of patients require tailored drug administration methods is also contributing to the market growth.

Key Market Trends: Numerous advancements in nanotechnology and biomaterials that facilitate precise drug delivery mechanisms, allowing for controlled release and better bioavailability, are positively influencing market growth. Moreover, the rising adoption of user-friendly drug delivery systems that can cater to the specific needs of elderly patients is also acting as another significant trend, driving the market growth.

Geographical Landscape: According to the report, North America accounted for the largest market share in the global market since the region has a robust healthcare infrastructure, strong research and development (R&D) capabilities, and a high prevalence of chronic diseases.

Competitive Landscape: Some of the leading pharmaceutical drug delivery market companies are AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi S.A., among many others.

Challenges and Opportunities: Challenges in the global pharmaceutical drug delivery market include regulatory hurdles, complex manufacturing processes, and the need for continuous innovation. Pharmaceutical drug delivery market recent opportunities include increasing prevalence of chronic diseases, growing demand for targeted and controlled drug delivery systems, and advancements in nanotechnology and biologics.

Pharmaceutical Drug Delivery Market Trends:

Rising Demand for Targeted Therapies

The escalating demand for targeted therapies is a significant driver in the pharmaceutical drug delivery market. Traditional systemic drug administration often results in off-target effects and adverse reactions, which augment the need for targeted therapies and drug deliveries. Moreover, the growing prevalence of various life-threatening infections, such as COVID-19, is also prompting manufacturers to introduce effective drug-delivery devices and techniques. This is anticipated to significantly contribute to the pharmaceutical drug delivery market growth in the coming years. For instance, in February 2022, Glenmark Pharmaceuticals Limited launched a nitric oxide nasal spray called FabiSpray in India for the treatment of adult patients with COVID-19 who had a high risk of progression of the disease. Besides this, the article published by Frontiers in July 2020 mentioned that it is necessary to develop appropriate delivery systems and complete therapy strategies according to the nature of drugs in treating diabetes mellitus. As per the source, drug-delivery devices have shown significant potential in various aspects of diabetes treatment. They enhance the stability of drugs, overcome biological barriers to increase bioavailability, and act as a smart, automated system to mimic natural insulin delivery, reducing the risk of hypoglycemia.

Rapid Technological Advancements

Ongoing technological advancements in drug delivery devices and techniques to make them more patient-friendly, accessible, and accurate are further catalyzing the growth of the global pharmaceutical drug delivery market. In addition to this, various key market players are extensively investing in the development and innovation of advanced drug-delivery devices. For instance, in May 2021, Phillips-Medisize launched its Aria Smart Autoinjector platform, which unlocked innovation, differentiation, and sustainability in the pharmaceutical industry. This device features advanced technologies such as a modular drug delivery platform that supports a variety of drug formulations and viscosities and has built-in Bluetooth, which enables connectivity to smartphones, tablets, and mobile apps. Similarly, in June 2021, Roche developed a Port Delivery System with ranibizumab (PDS), a drug delivery implant, to free patients with wet age-related macular degeneration from the need to undergo frequent eye injections. Such innovations and technological advancements are anticipated to propel the pharmaceutical drug delivery market revenue in the coming years.

Increasing Prevalence of Chronic Diseases

The rising cases of various chronic ailments across the world are augmenting the demand for medicines and drugs. According to the World Health Organization (WHO), chronic diseases are the leading cause of death worldwide. Ischemic heart disease alone was responsible for about 8.89 million deaths in 2019. Moreover, the increasing prevalence of cancer, respiratory disease, and diabetic patients across the world is further promoting the adoption of drug delivery devices. According to the data published by the International Agency for Research on Cancer 2020, globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die. Breast, colorectal, lung, cervical, and thyroid cancers are common among women. Whereas lung and prostate cancer are the most common among men, accounting for nearly one-third of all male cancers. Furthermore, according to a report published by the National Institute of Health, India, on Prevalence and Potential Determinants of Chronic Diseases, 2022, about 21% of the elderly population in India reportedly have at least one chronic disease. The escalating cases of chronic ailments are projected to bolster the pharmaceutical drug delivery market demand.

Global Pharmaceutical Drug Delivery Industry Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical drug delivery market report, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on route of administration, application, and end user.

Breakup by Route of Administration:

Oral Drug Delivery

Injectable Drug Delivery

Topical Drug Delivery

Ocular Drug Delivery

Pulmonary Drug Delivery

Implantable Drug Delivery

Transmucosal Drug Delivery

Nasal Drug Delivery

Oral drug delivery represents the most popular route of administration

The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral, injectable, topical drug, ocular, pulmonary, implantable, transmucosal, and nasal drug deliveries. According to the report, oral drug delivery represented the largest segment.

Pharmaceutical drug delivery market forecast indicates that oral drug delivery is a prominent route of administration where pharmaceutical compounds are ingested through the mouth and absorbed in the gastrointestinal tract. Oral medications are convenient to administer, making it a preferred choice for various medications. Moreover, the rise in R&D activities and product launches are likely to positively impact the pharmaceutical drug delivery market outlook. For instance, in June 2021, Shilpa Medicare Ltd. launched Molshil, a pediatric dose of paracetamol oral thin film, in India. Furthermore, according to the WHO, in 2021, approximately 275 million people used medications (drugs) at least once. Among them, approximately 62 million people used opioids.

Breakup by Application:

Infectious Diseases

Cancer

Cardiovascular Diseases

Diabetes

Respiratory Diseases

Central Nervous System Disorders

Autoimmune Diseases

Others

Infectious diseases account for the majority of the market share

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and others. According to the report, infectious diseases accounted for the largest market share.

Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, and parasites, which can spread from person to person or through contaminated objects. As per the pharmaceutical drug delivery market report by IMARC, the rising prevalence of infectious diseases poses significant global health challenges, necessitating effective treatment strategies. For instance, according to an article by Frontiers in February 2022, non-typhoidal Salmonella, a common cause of bacterial enteritis in humans, causes almost 93.8 million cases of gastroenteritis globally each year.

Breakup by End User:

Hospitals

Ambulatory Surgery Centers

Home Care Settings

Diagnostic Centers

Others

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgery centers, home care settings, diagnostic centers, and others.

As per the pharmaceutical drug delivery market overview by IMARC, hospitals hold a significant share in the global market. Hospitals as primary care providers utilize a variety of drug delivery methods to ensure effective treatment for diverse patient needs. Ambulatory Surgery Centers demand specialized drug delivery techniques for perioperative care and pain management. Home Care Settings require user-friendly delivery systems for patient self-administration, promoting adherence and comfort. Diagnostic Centers rely on targeted drug delivery to enhance imaging and therapeutic interventions.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

As per the pharmaceutical drug delivery market statistics by IMARC, North America held the biggest share in the market since the region has a robust healthcare infrastructure, strong research and development (R&D) capabilities, and a high prevalence of chronic diseases. For instance, according to the American Cancer Society's 2022 report, approximately 1.9 million new cancer cases were diagnosed in 2022 in the United States. Besides this, the presence of leading manufacturers in the region, along with the introduction of new products, is also bolstering the growth of the market in North America. For instance, in February 2022, the United States FDA approved the generic Apokyn (apomorphine hydrochloride injection) drug cartridges to treat hypomobility and other episodes associated with advanced Parkinson's disease.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

AbbVie Inc.

Amgen Inc.

AstraZeneca plc

Becton Dickinson and Company

Eli Lilly and Company

GSK plc

Johnson & Johnson

Merck KGaA

Novartis AG

Pfizer Inc.

Sanofi S.A.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Pharmaceutical Drug Delivery Market Recent Developments

January 2024: Berry Global Healthcare, a patient-centered package design company, showcased its latest range of standard and bespoke pharmaceutical packaging solutions at Pharmapack 2024. The exhibition witnessed the launch of the BerryHaler, an all-plastic, dual chamber, dry powder inhaler (DPI) designed to deliver combination drugs and separately store two medications for subsequent simultaneous inhalation.

October 2023: Victrex plc, a pioneer in the development of PEEK biomaterial solutions launched a new product grade developed exclusively for Drug Delivery and Pharmaceutical Contact applications. VICTREX PC101 meets the highest levels of Industry biocompatibility certification for USP Class VI and also meets industry standards such as USP 661 for use in non-implantable pharmaceutical contact applications.

July 2023: Viatris Inc., a global healthcare company, and Kindeva Drug Delivery L.P. announced the launch of Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the first generic version of AstraZeneca's Symbicort. It comes with an Abbreviated New Drug Application (ANDA) and is approved by the U.S. Food and Drug Administration (FDA).

Key Questions Answered in This Report:

  • How has the global pharmaceutical drug delivery market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical drug delivery market?
  • What are the key regional markets?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical drug delivery market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Drug Delivery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Route of Administration

  • 6.1 Oral Drug Delivery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injectable Drug Delivery
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Topical Drug Delivery
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Ocular Drug Delivery
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pulmonary Drug Delivery
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Implantable Drug Delivery
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Transmucosal Drug Delivery
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Nasal Drug Delivery
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Infectious Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diabetes
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Respiratory Diseases
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Central Nervous System Disorders
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Autoimmune Diseases
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Care Settings
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Diagnostic Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 AstraZeneca plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novartis AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Pfizer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: Pharmaceutical Drug Delivery Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Drug Delivery Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Pharmaceutical Drug Delivery Market: Breakup by Route of Administration (in %), 2023
  • Figure 5: Global: Pharmaceutical Drug Delivery Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Pharmaceutical Drug Delivery Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Pharmaceutical Drug Delivery Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Pharmaceutical Drug Delivery (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Pharmaceutical Drug Delivery (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Pharmaceutical Drug Delivery (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Pharmaceutical Drug Delivery (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Pharmaceutical Drug Delivery (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Pharmaceutical Drug Delivery (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Pharmaceutical Drug Delivery (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Pharmaceutical Drug Delivery (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: Pharmaceutical Drug Delivery (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: Pharmaceutical Drug Delivery (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: North America: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: North America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United States: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United States: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Canada: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Canada: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Asia-Pacific: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Asia-Pacific: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: China: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: China: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Japan: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Japan: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: India: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: India: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: South Korea: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: South Korea: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Australia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Australia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Indonesia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Indonesia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Europe: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Europe: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Germany: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Germany: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: France: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: France: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: United Kingdom: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: United Kingdom: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Italy: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Italy: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Spain: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Spain: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Russia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Russia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Latin America: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Latin America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Brazil: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Brazil: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Mexico: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Mexico: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: Middle East and Africa: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: Middle East and Africa: Pharmaceutical Drug Delivery Market: Breakup by Country (in %), 2023
  • Figure 98: Middle East and Africa: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 99: Global: Pharmaceutical Drug Delivery Industry: SWOT Analysis
  • Figure 100: Global: Pharmaceutical Drug Delivery Industry: Value Chain Analysis
  • Figure 101: Global: Pharmaceutical Drug Delivery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Drug Delivery Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 3: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Pharmaceutical Drug Delivery Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Drug Delivery Market: Key Players